Quality Improvement
Quality improvement is central to achieving high-value care. Learn how we collaborate with all industry stakeholders to identify and bridge measurement gaps and advance patient care.
Avalere White Paper: The State of Quality in Rare Disease
Avalere assessed quality measurement, quality improvement, and value-based initiatives in rare disease and the opportunity for a cohesive quality strategy.
Newest Standards of Care Continue to Reflect Advances in Diabetes Technology
Continued emphasis on diabetes management technology and patient-centered care in updated clinical management standards highlight the importance of advancing quality measurement.
Reevaluating Value Assessment for HEOR in 2023
Avalere identified the top trends in HEOR. In this Insight, Avalere experts dive into Trend #7: Value Assessment, and explore important considerations for stakeholders in utilizing this vital tool.
Potential Disparities in Home Dialysis Use
An analysis presented at ASN’s Kidney Week 2023 found lower rates of home dialysis utilization among Medicare dual eligibles compared to non-dual eligibles.
Health Spending Varies for Patients Likely to Have Obesity
Among Medicare FFS beneficiaries with diagnoses that are indicative of obesity, total healthcare spending rises dramatically as BMI group increases.
State of the GRACE Framework: ICER Pilots for HTAs
ICER recently proposed piloting the GRACE framework in place of traditional cost-effectiveness analysis. We review the background of GRACE and its implications.
Manufacturer Considerations for Rare-Disease Drug Development
The development and launch of rare disease therapies require tailored strategies that account for unique patient journeys and the broader evolving landscape.
MA Spending Lower than FFS for Those with Chronic Conditions
Updated Avalere analysis finds MA beneficiaries with chronic conditions had fewer inpatient stays and ED visits than FFS Medicare beneficiaries.
Hospital at Home: Opportunities for Manufacturers and Digital Health
The COVID-19 public health emergency and advancements in digital health technologies accelerated the adoption of Hospital at Home, a promising acute-care delivery model.
Diabetes Quality Measure Specifications Published by iDQI
New quality measures related to continuous glucose monitoring (CGM) were published in The Science of Diabetes Self-Management and Care by iDQI.
iDQI Corporate Roundtable Advances Diabetes Care Quality
On March 2, 2023, the Improving Diabetes Quality Initiative (iDQI) hosted a corporate roundtable to discuss the future of diabetes care and technology.
ESRD Enrollment Shifts in MA Driving Care Management Partnerships
Continued shifts in Medicare Advantage enrollment introduce new value-based care opportunities for patients with ESRD.
Shortening the Diagnostic Odyssey: Benefits, Barriers, and Solutions
A diagnostic odyssey is defined as the time between when a symptom or feature of a genetic or rare disease is noted to the time when a final diagnosis is made.
Standards of Care Begin to Reflect Advances in Diabetes Technology
Changes to standards related to diabetes technology indicate a corresponding opportunity to evolve quality measurements.
Laura Housman Joins Avalere, Strengthens Evidence & Strategy Team
As a new managing director in the Evidence & Strategy practice, Laura Housman brings deep expertise in the pharmaceutical, device, and healthcare industries.
Avalere Welcomes Return of Shareef Ghanem to Financial Services Team
Shareef Ghanem rejoins Avalere as a managing director, bringing more than 10 years of experience in due diligence, operations, and corporate strategy.
Treatment and Outcomes for MA and FFS Patients with Diabetes
Avalere released a white paper comparing detection, treatment, outcomes, and spending between MA and FFS Medicare for patients with type 2 diabetes.
How the ESRD Quality Incentive Program Drives Improvement
The ESRD QIP is the first pay-for-performance program that penalizes dialysis facilities for not meeting performance thresholds.
Fewer Highly Rated MA Plans in 2023 than in 2022
On October 6, CMS published the 2023 star ratings for Medicare Advantage (MA) plans ahead of the start of open enrollment on October 15.
New Opportunity for Quality Reporting Led by Avalere Health and Academy of Nutrition and Dietetics Will Improve Treatment for People With Malnutrition
Global Malnutrition Composite Score Included in Inpatient Prospective Payment System Final Rule